TCEAL7 and breast cancer: Consistently, our results revealed the role of NF-κB in the downstream pathway of miR-18b-TCEAL7 axis in breast cancer by demonstrating that TCEAL7 can inhibit NF-κB activation, thereby stabilizing Snail and ultimately inhibiting EMT.